Development Of Mice Models For Amyloidosis: A Rare Disease
                                
							
                            
                                
                                33/15/2019-TF/Rare/BMS
                                
							
						 
                        
                        
                            
                                
                                ICMR
                                
							
                            
                                
                                Jan. 6, 2020
                                
							
						 
                        
                        
                            
                                
                                July 5, 2023
                                
							
                            
                                
                                Three Years + six months extension
                                
							
						 
                        
                        
                            
                                
                                Amyloidosis
                                
                                
							
                            
                                
                                In vivo study
                                
							
						 
                        
                        
                            
                                
                                Quantitative data
                                
							
                            
                                
                                Development of mouse models of experimental amyloid A (AA) amyloidosis by different Chemical/biological means. Diagnosis/Detection of amyloidosis in mice by histopathological/immunological Methods
                                
							
						 
                        
                        
                            
                                
                                Amyloidosis, amyloid Enhancing Factor, Tuberculosis, Serum Amyloid A, BALB/c, ELISA
                                
							
                            
                                
                                The study will help in understanding the biology of amyloidosis and new drug targets can be produced. The development of animal models will lead to the study of disease progression in other chronic diseases.
                                
							
						 
                        
						
                            
                                
                                51,51,800/-
                                
							
						 
                        
						
                        
                            
                                
                                Dr. Vimal  Kumar/None/National Jalma Institute of leprosy and other micobacterial diseases ,Agra